Treace Medical Strengthens Position in Underserved Market Company Revenue The Numbers The company grew over 45% in 1Q23 as it further penetrates the large, underserved bunion surgical procedure market. May 15, 2023
Paragon 28 Remains Cautious Despite Hot Start to FY23 Company Revenue The Numbers The company grew 26% in 1Q23 against strong comps than most of the orthopedic industry, but opted to not increase it revenue guidance. May 15, 2023
Orthofix Completes First Quarter as Combined Company Company Revenue The Numbers The company grew 11.1% on a pro forma basis in 1Q23, driven by strength across its businesses and no major dissyngeries from the merge May 11, 2023
OrthoPediatrics Off To Better Than Expected Start for FY23 Company Revenue The Numbers The company grew more than 30% in the first quarter of 2023 despite ongoing staffing challenges at pediatric hospitals. May 11, 2023
Globus Starts 2023 with Momentum Company Revenue The Numbers The company grew 20% in 1Q23 due to improving procedure volumes, competitive rep recruiting and robotic pull-through. May 10, 2023
Conformis Customers Slow to Embrace New Business Model Company Revenue The Numbers The company's 1Q23 sales declined in the high teens as its business model shift and operational challenges take a toll. May 10, 2023
Enovis Rides Momentum from Scaling Acquisitions Company Revenue The Numbers The company grew in the high teens in 1Q23 due to easing market pressures in the U.S. and some international markets in "overdrive." May 09, 2023
ATEC Positions for Informatics Arms Race Company Revenue The Numbers The company grew 54% in 1Q23 and acquired the REMI navigated robotics system as ATEC prepares for the modernization of spine surgery. May 09, 2023
Zimmer Biomet Takes Advantage of Easing Market Pressure Company Revenue The Numbers The company grew in the low double-digits for 1Q23, driven by easier comps from the prior year, easing market pressure and new products. May 08, 2023
ZimVie Rounding Corner on Spine Turnaround Company Revenue The Numbers The company's spine business declined in the high-single-digits in 1Q23 but will benefit from more commercial focus in 2023. May 08, 2023